Clorox (NYSE:CLX) Q4 CY2025: Revenue Beat, Flat Sales

[Para 1: The Lead] Clorox (NYSE:CLX) reported Q4 CY2025 revenue of $1.67 billion, surpassing market expectations. Non-GAAP earnings per share were $1.39, 3% below consensus. The company's sales were flat year-over-year. [Para 2-3: Supporting details & Context] Clorox, a leading consumer products giant, saw its revenue remain stable at $1.67 billion, beating Wall Street estimates by 1.9%. However, organic sales fell 1% year-over-year, a reversal from historical growth trends. EPS missed analyst estimates, while gross margins were slightly below Wall Street projections. Despite the mixed results, Clorox reaffirmed its fiscal year outlook amidst a challenging market environment. Shares closed down 3.4% post-earnings to $111.05. Long-term, Clorox's revenue growth has been sluggish, with organic sales growth averaging 1.9% annually over the past eight quarters. The company's scale presents a double-edged sword, offering strong brand influence but limited growth avenues.